A $2.4 million exchange of outstanding warrants for 2 million new shares of common stock has been announced by InVivo Therapeutics. The warrants were issued as part of a financing deal three years ago.
InVivo swaps warrants for common stock in $2.4M exchange
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.